Hamdan A H, Shaw N J
Regional Neonatal Intensive Care Unit, Liverpool Maternity Hospital.
Arch Dis Child Fetal Neonatal Ed. 1995 May;72(3):F176-9. doi: 10.1136/fn.72.3.f176.
The pulmonary artery pressure (PAP) changes were studied using Doppler echocardiography in preterm infants treated with an artificial surfactant (Exosurf) during the acute phase of respiratory distress syndrome (RDS). The ratio of pulmonary artery acceleration time to the right ventricular ejection time (AT:RVET), measured from the Doppler wave form, was determined in 38 infants before the first dose of Exosurf, at one and six hours after the first dose, immediately before the second dose of Exosurf, and at one, six, 12, 36, and 60 hours subsequently. The median AT:RVET ratio corrected for heart rate (AT:RVET(c)) increased significantly an hour after administration of the first dose of Exosurf from 0.330 (0.273-0.410) to 0.380 (0.303-0.445) and similarly an hour after the second dose from 0.426 (0.252-0.495) to 0.440 (0.373-0.500). These changes occurred against a steady increase in the median AT:RVET(c) over the first 72 hours. It is concluded that the reduction in PAP correlates well with clinical parameters of disease severity and raises questions regarding the mode of action of Exosurf.
在呼吸窘迫综合征(RDS)急性期,使用多普勒超声心动图研究了接受人工表面活性剂(Exosurf)治疗的早产儿的肺动脉压(PAP)变化。从多普勒波形测量的肺动脉加速时间与右心室射血时间之比(AT:RVET),在38例婴儿首次给予Exosurf之前、首次给药后1小时和6小时、即将给予第二次Exosurf之前以及随后的1、6、12、36和60小时测定。校正心率后的AT:RVET中位数比值(AT:RVET(c))在首次给予Exosurf后1小时显著增加,从0.330(0.273 - 0.410)增至0.380(0.303 - 0.445),第二次给药后1小时也类似地从0.426(0.252 - 0.495)增至0.440(0.373 - 0.500)。这些变化是在最初72小时内AT:RVET(c)中位数持续增加的背景下发生的。结论是PAP的降低与疾病严重程度的临床参数密切相关,并引发了关于Exosurf作用方式的问题。